XML 51 R41.htm IDEA: XBRL DOCUMENT v3.23.1
Investments - Summary of Information Relating to Investments Measured at Fair Value for Company has Used Unobservable Inputs to Determine Fair Value (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Beginning balance $ 471,170 $ 465,706
Transfers out of Level III (5,585) [1] (11,239) [2]
Transfers into Level III 6,519 [3] 9,432 [4]
Net accretion 2,745 4,916
Purchases 8,948 53,926
Sales/Paydowns/Return of Capital (35,203) (40,828)
Total realized gain (loss) included in earnings (3,054) (5,554)
Change in unrealized gain (loss) included in earnings (5,414) 2,739
Ending balance 440,126 479,098
Changes in unrealized gains (losses) included in earnings related to investments still held at reporting date (8,033) 3,737
Debt securities    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Beginning balance 410,144 392,432
Transfers out of Level III (5,585) [1] (11,239) [2]
Transfers into Level III 6,519 [3] 9,432 [4]
Net accretion 2,197 3,282
Purchases 8,880 53,926
Sales/Paydowns/Return of Capital (29,317) (38,627)
Total realized gain (loss) included in earnings (31) (3,671)
Change in unrealized gain (loss) included in earnings (3,318) 1,444
Ending balance 389,489 406,979
Changes in unrealized gains (losses) included in earnings related to investments still held at reporting date (6,986) (2,752)
Equity Securities    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Beginning balance 21,905 20,992
Purchases 68  
Sales/Paydowns/Return of Capital (5,429) (2,257)
Total realized gain (loss) included in earnings 858 212
Change in unrealized gain (loss) included in earnings (2,082) 2,069
Ending balance 15,320 21,016
Changes in unrealized gains (losses) included in earnings related to investments still held at reporting date (1,032) 2,216
CLO Fund Securities    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Beginning balance 20,453 31,632
Net accretion 548 1,634
Sales/Paydowns/Return of Capital (457) (2,032)
Total realized gain (loss) included in earnings (3,881)  
Change in unrealized gain (loss) included in earnings 2,578 (2,177)
Ending balance 19,241 29,057
Changes in unrealized gains (losses) included in earnings related to investments still held at reporting date 2,578 (2,177)
Joint Ventures    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Beginning balance 18,668 23,062
Change in unrealized gain (loss) included in earnings (2,592) (1,039)
Ending balance 16,076 22,023
Changes in unrealized gains (losses) included in earnings related to investments still held at reporting date $ (2,592) (1,039)
Derivatives    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Beginning balance   (2,412)
Sales/Paydowns/Return of Capital   2,088
Total realized gain (loss) included in earnings   (2,095)
Change in unrealized gain (loss) included in earnings   2,442
Ending balance   23
Changes in unrealized gains (losses) included in earnings related to investments still held at reporting date   $ 14
[1] Transfers out of Level III represent a transfer of $5.6 million relating to debt securities for which pricing inputs, other than their quoted prices in active markets were observable as of March 31, 2023.
[2] Transfers out of Level III represent a transfer of $11.2 million relating to debt securities for which pricing inputs, other than their quoted prices in active markets were observable as of March 31, 2022.
[3] Transfers into Level III represent a transfer of $6.5 million relating to debt securities for which pricing inputs, other than their quoted prices in active markets were unobservable as of March 31, 2023.
[4] Transfers into Level III represent a transfer of $9.4 million relating to debt securities for which pricing inputs, other than their quoted prices in active markets were unobservable as of March 31, 2022.